Compare Honest Company Inc (HNST) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honest Company Inc vs IDEXX Laboratories, Inc. — how do they compare? Honest Company Inc trades at $3.81 (market cap $427.66M), while IDEXX Laboratories, Inc. trades at $543.91 (market cap $43.58B). The key difference: IDEXX Laboratories, Inc. is far larger — about 101.9× Honest Company Inc's market cap, and Honest Company Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| HNST | IDXX | |
|---|---|---|
Market Cap | $427.66M | $43.58B |
Sector | Consumer Staples | Health |
52-Week High | $4.95 | $766.68 |
52-Week Low | $2.10 | $526.44 |
Enterprise Value | $349.05M | $44.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HNST trades at $3.89, up 1.57% with a bullish technical signal. The company shows mixed fundamentals with revenue of $371.32M in 2025 but negative net income of -$15.69M. Recent earnings show one beat and two misses, while cash flow improved to $14.15M net. Analyst consensus is divided with 30% buy, 50% hold ratings. The company announced Q2 2026 results for August 5, 2026, alongside leadership updates.
Outlook remains cautious due to persistent losses and margin pressure, though strategic shifts to retail and cost controls offer potential. Key risks include competitive intensity and execution challenges. The stock presents speculative appeal for turnaround believers but requires monitoring of profitability improvements.
IDEXX Laboratories trades at $552.46, down 2.64% today, with neutral technical signals but strong fundamental performance. The company maintains robust profitability with 24.63% net margins and has beaten earnings expectations for three consecutive quarters. Recent news highlights AI integration in medical devices and upcoming Q2 2026 results on August 4, 2026. The stock shows consistent revenue growth from $3.4B in 2022 to $4.3B in 2025.
Outlook remains positive given earnings momentum and analyst consensus, though elevated valuation ratios (P/E 41.49) pose risks. Key catalysts include Q2 earnings release and continued AI adoption in veterinary diagnostics. Primary risks involve competitive pressures and market volatility affecting premium valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honest Company Inc
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
